KCT0002177招募中未知
Evaluation of Efficacy and Safety of Herbal Medicine on Work related Chronic Low Back Pain - Multicenter, Randomized, Double Blinded, Parallel Group, Placebo Controlled Pilot study
Gil Korean Medicine Hospital, Gachon University0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 65(Year)（—）
- 性别
- All
入选标准
- •1) Inpatients with Chief Complaint of Low Back Pain in Oriental Rehabilitation Medical Center
- •2) Age 19 - 65
- •3) Occupations Designated As High-Risk Or Safety-Sensitive to low back pain(hospital worker, office worker, blue collar, vehicle driver)
- •4) Satisfying all of the following criteria
- •- Numeric rating scale 4-7 points
- •- Diagnosed with at-risk worker or worker with pain by using musculoskeletal disorder questionnaire(KOSHA)
- •5) Ability to have normal communication
- •6) Ability to give informed consent
排除标准
- •1. Patients with pain duration of 3 months or less
- •2. Patients with progressive neurologic deficit or severe neurologic symptoms by SLR test
- •3. Patients diagnosed with serious pathology(s) which may cause low back pain (e.g. spinal metastasis of tumor(s), acute fracture, etc)
- •4. Patients with spondylolisthesis or spondylolysis(diagnosed with grade II or higher level)
- •5. Patients currently taking steroids, immunosuppressants, medicine for mental illness or other medication(s) that may interfere with study results
- •6. Patients with history of spinal surgery
- •7. Patients with more severe pain than pain caused by low back pain
- •8. Those who do not (cannot) abide by treatment and follow up due to the mental illness such as behavior disorder, depression, anxiety neurosis etc.
- •9. Patients with history of Medical Malpractice Case
- •10. Patients with treatment history of low back pain within 1 month either KM or WM
- •11. Patients participating in other clinical studies within 3 months
- •12. Pregnant patients or patients with plans of pregnancy or lactating patients
- •13. Patients disagree to sign the informed consent form
- •14. Patients deemed unsuitable for participating the trial by the researchers
研究者
相似试验
进行中（未招募）
不适用
Evaluation of efficacy and safety of the herbal drug Myrrhinil-Intest vs. mesalazine in maintaining clinical remission of ulcerative colitis - a 12-month, multicenter, randomized, prospective, double-blind, double-dummy, active-controlled and parallel group phase IV-trial - MIRCulcerative colitis patients in clinical remissionMedDRA version: 9.1Level: LLTClassification code 10045365Term: Ulcerative colitisEUCTR2007-007928-18-DEREPHA GmbH
招募中
3 期
Effect of herbal medicine containing Saatar, Hofarigon and Fennel on COVID-19 patientsIRCT20200404046935N1Mazandaran University of Medical Sciences40
已完成
3 期
Efficacy and Safety of an Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence: A Prospective, Placebo Controlled, Randomized, double-blinded Parallel-Group Comparison for SuperiorityAcute Otitis Media (AOM)H65.0 und H66.0Upper respiratory tract infectionH65.0H66.0Acute serous otitis mediaAcute suppurative otitis mediaDRKS00004569Weber & Weber GmbH & Co. KGBiologische Arzneimittel311
进行中（未招募）
不适用
Does a herbal-based medicine compared with a placebo (dummy drug) reduce the number of episodes with middle ear infection?recurrent acute otitis mediaMedDRA version: 16.1Level: PTClassification code 10033078Term: Otitis mediaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 16.1Level: PTClassification code 10033079Term: Otitis media acuteSystem Organ Class: 10021881 - Infections and infestationsEUCTR2012-000341-13-DEWeber & Weber GmbH & Co. KG
招募中
Unknown
Efficacy and Safety of the HH333 on the Prevention of Ischemic Stroke Recurrence by Small Vessel DiseaseDiseases of the circulatory systemKCT0009431Kyung Hee University Oriental Medical Center236